Harvard’s Safra Center has put together an extremely valuable “symposium of 16 articles that investigate the corruption of pharmaceutical policy, each taking a different look at the sources of corruption, how it occurs and what is corrupted. The articles address five topics: (1) systemic problems, (2) medical research, (3) medical knowledge and practice, (4) marketing, and (5) patient advocacy organizations.”
Institutional Corruption and Pharmaceutical Policy
An Edmond J. Safra Center SymposiumÂ
Harvard University
Journal of Law, Medicine and EthicsÂ
Vol. 14, No. 3 (2013)
An Edmond J. Safra Center SymposiumÂ
Harvard University
Journal of Law, Medicine and EthicsÂ
Vol. 14, No. 3 (2013)
-
Marc Rodwin, Institutional Corruption and Pharmaceutical Policy
-
Lawrence Lessig, Foreword: ‘Institutional Corruption’ Defined
1. SYSTEMIC PROBLEMS
-
Marc A. Rodwin, Five Un-Easy Pieces of Pharmaceutical Policy Reform
-
Donald W. Light, Joel Lexchin, Jonathan J. Darrow, Institutional Corruption of Pharmaceuticals and the Myth of Safe and Effective Drugs
2. MEDICAL RESEARCH
-
Yuval Feldman, Rebecca L. Gauthier, and Troy H. Schuler, Curbing Misconduct in the Pharmaceutical Industry: Insights from Behavioral Ethics and the Behavioral Approach to Law
3. MEDICAL KNOWLEDGE AND PRACTICE
-
Lisa Cosgrove and Emily E. Wheeler, Drug Firms, the Codification of Diagnostic Categories, and Bias in Clinical Guidelines
4. MARKETING
-
Sunita Sah and Adriane Fugh-Berman, Physicians Under the Influence: Social Psychology and Industry Marketing Strategies
-
Amy Snow Landa and Carl Elliott, From Community to Commodity: The Ethics of Pharma-Funded Social Networking Sites for Physicians
5. PATIENT ADVOCATES
Hat tip to 1BoringOldMan and Ben Goldacre
